Tom Brady Named Chief Wellness Officer for GLP-1 Health Platform
NewBeauty Facebook Pinterest Instagram Youtube find a doctor Face Adult Acne Antioxidants Anti-Aging Celebrity Chronic Skin Conditions Eye Hydration Hyperpigmentation Makeup View All Eyebrows Eye Color Foundation Fragrance Lip Color Makeovers Male Skin Care Peels Pre-Event Prep Sensitive Skin Skin Care Skin Health Smile Sun Care Treatments Fillers Microneedling Post-Procedure Skin Care Neurotoxins Regenerative Aesthetics Skin Lifting Body Body Sculpting Breasts Butts Cellulite Hair Removal Hands + Nails Legs Pregnancy Find a Doctor Hair Bond Repair Celebrity Dry Hair Frizzy Hair Gray Hair Hair Color Hair Growth Hair Repair Scalp Health Styling + Tips Awards NB100 Awards 15th Annual Beauty Awards 2025 NewBeauty Readers’ Choice Awards Shopping Gift Guides Product Reviews NewBeauty Storefront Wellness Fitness GLP-1s Health Menopause About Us TESTTUBE Search for: Search HomeWellnessGLP-1s Tom Brady Named Chief Wellness Officer for GLP-1 Health Platform A powerful new name steps into the category. Tatiana Bido Published: Jan 13, 2026 Brooke Sutton/Getty Images GLP-1 celebrity headlines used to be all about personal reveals: who’s on it, who isn’t and who’s “never looked better.” But the newest name in the mix isn’t a celebrity confessing to taking a weight-loss shot. Instead, it’s a superstar stepping in on the business side. Football legend Tom Brady has been named Chief Wellness Officer at eMed Population Health, a digital platform that works with employers to manage the rising demand and high costs of GLP-1 medications like Wegovy and Zepbound. The company positions itself as a more structured, medically supervised option for workforce programs, offering clinical oversight, prescribing support and ongoing monitoring. “High-quality medical care should be accessible and delivered responsibly with decisions grounded in medical evidence and individual needs,” Brady said in a press release. “At eMed, the focus is improving population health at scale by delivering best-in-class GLP-1 care to the workforce populations. These…